Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

Japanese drugmaker Astellas Pharma (TYO: 4503) today announced an exclusive license agreement with China’s Evopoint ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...

Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...

Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...

Shares in US biotech Intellia Therapeutics (Nasdaq: NTLA) slid by a quarter on Thursday following a safety update from its ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...

US biotech Regeneron and French drugmaker Sanofi are reviewing next steps for their experimental COPD therapy itepekimab ...

Vima Therapeutics, a Cambridge, USA-based clinical-stage biotechnology company focused on oral therapies for movement ...

Japanese drugmaker Eisai (TYO: 4523) said yesterday that it has received a favorable decision regarding the lawsuit filed in ...

Swiss eye care specialist Alcon (SIX/NYSE: ALC) yesterday revealed the US Food and Drug Administration (FDA) has approved ...